PR
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Norges
· Exited
−$122M
Change
−833K
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | −$122M | −833K | −100.0% | Q1 2026 | |||||
|
Boston Partners
· Exited
−$62M
Change
−420K
Δ Own
−100.0%
Date
Q1 2026
|
Boston Partners | Exited· Q1 2026 | −$62M | −420K | −100.0% | Q1 2026 | |||||
|
Qube Research & Technologies Ltd
· Reduced
−$43M
Change
−293K
Date
Q1 2026
|
Qube Research & Technologies Ltd | Reduced· Q1 2026 | −$43M | −293K | – | Q1 2026 | |||||
|
Encompass Capital Advisors LLC
· Exited
−$42M
Change
−290K
Δ Own
−100.0%
Date
Q1 2026
|
Encompass Capital Advisors LLC | Exited· Q1 2026 | −$42M | −290K | −100.0% | Q1 2026 | |||||
|
D. E. Shaw & Co., Inc.
· Reduced
−$41M
Change
−280K
Δ Own
−47.4%
Date
Q1 2026
|
D. E. Shaw & Co., Inc. | Reduced· Q1 2026 | −$41M | −280K | −47.4% | Q1 2026 | |||||
|
Westfield Capital Management Co LP
· Reduced
−$31M
Change
−209K
Date
Q1 2026
|
Westfield Capital Management Co LP | Reduced· Q1 2026 | −$31M | −209K | – | Q1 2026 | |||||
|
Jacobs Levy Equity Management, Inc
· Reduced
−$30M
Change
−208K
Date
Q1 2026
|
Jacobs Levy Equity Management, Inc | Reduced· Q1 2026 | −$30M | −208K | – | Q1 2026 | |||||
|
Arrowstreet Capital, Limited Partnership
· Reduced
−$24M
Change
−163K
Date
Q1 2026
|
Arrowstreet Capital, Limited Partnership | Reduced· Q1 2026 | −$24M | −163K | – | Q1 2026 | |||||
|
Nuveen, LLC
· Reduced
−$20M
Change
−135K
Date
Q1 2026
|
Nuveen, LLC | Reduced· Q1 2026 | −$20M | −135K | – | Q1 2026 | |||||
|
Alliancebernstein L.P.
· Reduced
−$18M
Change
−126K
Date
Q1 2026
|
Alliancebernstein L.P. | Reduced· Q1 2026 | −$18M | −126K | – | Q1 2026 | |||||
|
Incline Global Management LLC
· Exited
−$17M
Change
−117K
Δ Own
−100.0%
Date
Q1 2026
|
Incline Global Management LLC | Exited· Q1 2026 | −$17M | −117K | −100.0% | Q1 2026 | |||||
|
Van Berkom & Associates Inc.
· Reduced
−$16M
Change
−110K
Date
Q1 2026
|
Van Berkom & Associates Inc. | Reduced· Q1 2026 | −$16M | −110K | – | Q1 2026 | |||||
|
Wells Fargo & Company
· Reduced
−$16M
Change
−109K
Date
Q1 2026
|
Wells Fargo & Company | Reduced· Q1 2026 | −$16M | −109K | – | Q1 2026 | |||||
|
Merewether Investment Management, LP
· Reduced
−$16M
Change
−107K
Date
Q1 2026
|
Merewether Investment Management, LP | Reduced· Q1 2026 | −$16M | −107K | – | Q1 2026 | |||||
|
Mackenzie Financial Corp
· Reduced
−$15M
Change
−100K
Date
Q1 2026
|
Mackenzie Financial Corp | Reduced· Q1 2026 | −$15M | −100K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
McCallister Terry D.
· Director
Buy
+$2K
|
McCallister Terry D. | Director | Buy | $86.66 | +20 | +$2K | 21K | +0.1% | Jul 15, 2026 | Jul 17, 2026 | |||||||||
|
Perisich John M.
· Officer
6 operations
−$3.8M
|
Perisich John M. | Officer | 6 operations | $125.75–$130.26 | −30K | −$3.8M | 0 | – | May 28, 2026 | May 29, 2026 | |||||||||
|
Vadlamudi Koti
· Director
Grant (A)
$1.0M
|
Vadlamudi Koti | Director | Grant (A) | $127.96 | 8K | $1.0M | 8K | – | May 27, 2026 | May 28, 2026 | |||||||||
|
King David Lee
· Director
3 operations
−$2.4M
|
King David Lee | Director | 3 operations | $118.55–$120.27 | −20K | −$2.4M | 15K | – | May 26, 2026 | May 28, 2026 | |||||||||
|
Ching Michael E.
· Director
Grant (A)
268
|
Ching Michael E. | Director | Grant (A) | – | 268 | – | 10K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
Rodriguez Jose Ramon
· Director
Grant (A)
268
|
Rodriguez Jose Ramon | Director | Grant (A) | – | 268 | – | 18K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
Mashinski Carla S.
· Director
Grant (A)
268
|
Mashinski Carla S. | Director | Grant (A) | – | 268 | – | 22K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
Wagner Patricia K.
· Director
Grant (A)
268
|
Wagner Patricia K. | Director | Grant (A) | – | 268 | – | 3K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
Schauerman John P.
· Director
Grant (A)
268
|
Schauerman John P. | Director | Grant (A) | – | 268 | – | 6K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
McCallister Terry D.
· Director
Grant (A)
268
|
McCallister Terry D. | Director | Grant (A) | – | 268 | – | 21K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
Saluja Harpreet
· Director
Grant (A)
268
|
Saluja Harpreet | Director | Grant (A) | – | 268 | – | 1K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
King David Lee
· Director
Grant (A)
268
|
King David Lee | Director | Grant (A) | – | 268 | – | 35K | – | Apr 30, 2026 | May 1, 2026 | |||||||||
|
McCallister Terry D.
· Director
Buy
+$2K
|
McCallister Terry D. | Director | Buy | $164.40 | +10 | +$2K | 21K | – | Apr 15, 2026 | Apr 17, 2026 | |||||||||
|
Kinch Jeremy
· Officer
2 operations
0
|
Kinch Jeremy | Officer | 2 operations | – | 0 | – | 9K | – | Apr 1, 2026 | Apr 2, 2026 | |||||||||
|
Kinch Jeremy
· Officer
2 operations
0
|
Kinch Jeremy | Officer | 2 operations | – | 0 | – | 26K | – | Apr 1, 2026 | Apr 2, 2026 | |||||||||
501 reporting institutions disclosed PRIM position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.